Kaya Holdings (KAYS) Amortization of Deferred Charges (2014 - 2025)

Kaya Holdings (KAYS) recorded quarterly Amortization of Deferred Charges of $531677.0 in Q3 2025, up 9377.31% quarter-over-quarter from $5610.0 in Q2 2025, and up 444.66% on a YoY basis from $97616.0 in Q3 2024.

Kaya Holdings (KAYS) Amortization of Deferred Charges (2014 - 2025) Analysis & Trends

Kaya Holdings' Amortization of Deferred Charges history runs 12 years deep, the most recent figure standing at $531677.0 for Q3 2025.

  • In Q3 2025, Amortization of Deferred Charges rose 444.66% year-over-year to $531677.0; the TTM figure through Sep 2025 stood at $553029.0 (up 382.97% YoY), while the FY2024 annual figure was $119029.0, up 429.02% from the prior year.
  • Amortization of Deferred Charges was $531677.0 for Q3 2025 at Kaya Holdings, up from $5610.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $531677.0 in Q3 2025 to a low of -$232724.0 in Q3 2023.
  • Historically, Amortization of Deferred Charges has averaged $80585.1 across 5 years, with a median of $60113.0 in 2021.
  • The sharpest annual moves came in 2021 and 2023: Amortization of Deferred Charges surged 967.55% in 2021, then plunged 3619.19% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $60112.0 in 2021, then jumped by 132.2% to $139581.0 in 2022, then tumbled by 95.94% to $5671.0 in 2023, then soared by 79.76% to $10194.0 in 2024, then soared by 5115.59% to $531677.0 in 2025.
  • The last three Amortization of Deferred Charges figures came in at $531677.0 (Q3 2025), $5610.0 (Q2 2025), and $5548.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn
10 Kaya Holdings - - 5,370.00

Historic Data

Download Data
DateValue
Sep 30, 2025 531,677.00
Sep 30, 2025 531,677.00
Jun 30, 2025 5,610.00
Jun 30, 2025 5,610.00
Mar 31, 2025 5,548.00
Mar 31, 2025 5,548.00
Dec 31, 2024 10,194.00
Dec 31, 2024 10,194.00
Sep 30, 2024 97,616.00
Sep 30, 2024 97,616.00
Jun 30, 2024 5,609.00
Jun 30, 2024 5,609.00
Mar 31, 2024 5,610.00
Mar 31, 2024 5,610.00
Dec 31, 2023 5,671.00
Dec 31, 2023 5,671.00
Sep 30, 2023 -232,724.00
Sep 30, 2023 -232,724.00
Jun 30, 2023 68,010.00
Jun 30, 2023 68,010.00